Tandem Diabetes Care, Inc. (TNDM) announced that the in-warranty users of the t:slim X2 insulin pump in Canada can now access full compatibility with both Dexcom’s (DXCM) G7 and G6 Continuous Glucose Monitoring (“CGM”) systems. This follows Health Canada’s sale authorization in July 2024, making t:slim X2 with Control-IQ technology the first and only insulin pump in Canada to be integrated with both systems.The commercial availability of this new offering reflects the decade-long partnership between the two ...